Advertisment

Clinical trials get a new tech-try at Biogen

Tries to address data exchange, support of clinical operations and better monitoring of clinical trial progress

author-image
Pratima Harigunani
New Update
ID

NEW JERSEY, USA: Biogen has selected Cognizant’s SmartTrials platform to aggregate and store clinical trial operational and patient data, as an announcement informs.

Advertisment

Cognizant explains that the SmartTrials platform provides real-time risk assessment and global clinical trial oversight to help companies reduce risk and improve collaboration, quality and compliance; delivers actionable outcomes for faster data-driven decisions, transforming clinical operations into a more agile, innovative and efficient process.

The SmartTrials platform is also claimed to allow biopharma companies to support clinical operations by standardizing data exchange, and replacing several data repositories with a centralized information hub.

“We are excited to partner with leading biopharma companies to drive innovation in clinical development,” said Bhaskar Sambasivan, Vice President of Life Sciences practice at Cognizant. “The SmartTrials platform makes it easier for users and decision makers to more effectively monitor clinical trial progress, reduce risk and costs, with the goal of bringing new therapies to market faster.”

Cambridge, Mass.-based Biogen has a portfolio of medicines to treat multiple sclerosis (MS) and works in the area of neurology research to develop novel therapies for conditions with few or no treatment options.

healthcare data